"Designing Growth Strategies is in our DNA"

Neurotrophins Market Size, Share, And COVID-19 Impact Analysis, By Type (Brain Derived Neurotrophic Factor, Nerve Growth Factor, Glial Cell Line-Derived Neurotrophic Factor, Ciliary Neurotrophic Factor, And Others), By Application (Alzheimer Disease, Parkinson Disease, Cancer, And Others), By End-User (Hospitals & Clinics, Diagnostic Centers, And Others), And Regional Forecast, 2024-2032

Region :Global | Report ID: FBI107711 | Status : Ongoing

 

KEY MARKET INSIGHTS

Neurotrophins are proteins comprising several neurotrophic factors that are known to support the survival of different classes of embryonic neurons. The neurotrophic factors are responsible for enhancing neuronal differentiation, inducing proliferation, influencing synaptic functions, and promoting the survival of neurons. The main drivers for the neurotrophins market are the growing focus and trials on using novel regenerative therapeutics and minimally invasive approaches.



  • For instance, in March 2022, according to an article published by NCBI (National Center for Biotechnology Information), neurotrophins, specifically BDNF (Brain Derived Neurotrophic Factor) and NGF (Nerve Growth factor), administered directly and indirectly have a growing role in increasing neurogenesis and functional recovery after stroke and TBI (traumatic brain injury) and that BDNF and NGF have a synergistic role in motor learning and cognitive recovery.


Moreover, an increase in the prevalence of neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease, growing public awareness of the harmful implications, breakthroughs in regenerative therapeutics, and the emergence of rare diseases are the key factors driving the neurotrophin market.


  • For instance, according to a report by the Alzheimer's Association, an estimated 6.5 million Americans age 65 and older are living with Alzheimer's in 2022, and 12.7 million people are projected to have Alzheimer’s dementia by 2050.

  • In January 2022, according to an article published by BioMed Central Ltd, the number of cases of dementia in the developed world is projected to rise from 13.5 million in 2000 to 21.2 million in 2025 and to 36.7 million in 2050.


Impact of Covid-19 on the Neurotrophins Market


COVID-19 negatively impacted the neurotrophins market in 2020 owing to the imposed lockdowns and the worldwide compelled social isolation by the World Health Organization. Moreover, shifted focus toward treating COVID-19 patients worldwide and halting other clinical trials negatively impacted the market.


  • In May 2020, According to the report published by Elsevier Inc., thousands of clinical trials were suspended or stopped because of the difficulties in continuing under lockdown conditions.


Additionally, during the pandemic, key players faced delays in getting approvals from regulatory bodies for developing the neurotrophic drug for neurodegenerative diseases.


  • For instance, in December 2022, according to an article published by Athira Pharma, Inc., regulatory agencies caused delays in reviewing, commenting on or approving any of Athira’s clinical development plans as a result of the COVID-19 pandemic, and also the company was not able to recruit sufficient patients for its clinical trials, which further delayed the development timelines.


Key Insights



  • Prevalence of Key Diseases, By Key Countries/Region.

  • Technological advancements in Neurotrophins.

  • Key Industry Developments Mergers, Acquisitions, and Collaborations.

  • Impact of COVID-19 on the Neurotrophins market.


Analysis by Type


In 2022, the BDNF (Brain Derived Neurotrophic Factor) segment is the prominently growing segment of the hereditary testing market. Major players are increasing their focus on new developments and commercial strategies to strengthen their position in the market. Furthermore, the increasing number of research and clinical trials for using BDNF (Brain Derived Neurotrophic Factor) to treat Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases is expected to drive the market in the forecast period.


  • For instance, in February 2020, according to a study published by MDPI (Molecular Diversity Preservation International) showed that the administration of BDNF (Brain Derived Neurotrophic Factor) increased the survival of neuronal-nuclei-stained neuronal cells and dopaminergic neurons in substantia nigra (SN), a part of the brain. Moreover, BDNF administration increased dopamine levels in patients and restored dopamine uptake, further assisting as a therapeutic agent in Parkinson’s disease.


Regional Analysis


To gain extensive insights into the market, Request for Customization


North America accounts for a large share of the global neurotrophins market due to the rising incidences of neurodegenerative diseases and the increasing number of clinical trials for treating Alzheimer’s disease and other neurodegenerative disorders in the region, anticipated to drive the market in North America during the forecast period.


  • For instance, according to an article published by Alzheimer's Association in May 2021, the development of drugs used in treating Alzheimer's disease, 37.0% of phase 3 clinical trials, 60.0% of phase 2 clinical trials and 63.0% of phase 1 clinical trials for Alzheimer’s disease are conducted in North America.


Additionally, the increasing prevalence of aged population suffering from Alzheimer’s disease is expected to drive the adoption of neurotrophins for the treatment and clinical trials in the region during the forecast period.


  • For instance, in September 2022, according to a study published by Case Western Reserve University,  U.S., more than 6.0 million patients aged 65 and above, show a substantially 50.0%-80.0% higher risk of developing Alzheimer's within a year.


Key Players Covered


The report will include the profiles of key players such as PeproTech, Inc., Prospec-Tany Technogene Ltd., ROCKLAND IMMUNOCHEMICALS, INC., ACROBiosystems, Merck KGaA, R&D Systems Inc, HERANTIS PHARMA Plc., BRIM Biotechnology, Inc., and others.

Segmentation


















By Type


By Application


By End User


By Geography



  • Brain Derived Neurotrophic Factor

  • Nerve Growth factor

  • Glial cell line-derived neurotrophic factor

  • Ciliary neurotrophic factor

  • Others




  • Alzheimer’s Disease

  • Parkinson’s Disease

  • Cancer

  • Others




  • Hospitals & Clinics

  • Diagnostic Centers

  • Others




  • North America (U.S. and Canada)

  • Europe (U.K., Germany, France, Spain, Italy, and the Rest of Europe)

  • Asia Pacific (India, Japan, China, Australia, and the Rest of APAC)

  • Rest of the world



Key Industry Developments



  • October 2021: Nanoform Finland Oyj, and HERANTIS PHARMA Plc., focused on disease-modifying therapies for neurodegenerative diseases based on the natural body protein CDNF (Cerebral Dopamine Neurotrophic Factor), announced results from the Nanoform Proof of Concept (PoC) project, showing that the nano forming process has been successfully applied to Herantis’ rhCDNF drug candidate. The aim was to assess the potential of Nanoform’s platform technology to improve the administration of rhCDNF via a minimally invasive intranasal spray route.

  • February 2020: Merck KGaA launched the SMC (single molecule counting) Human Brain-Derived Neurotrophic Factor (BDNF) High Sensitivity Immunoassay Kit, containing all reagents used for the research process in Alzheimer’s disease.





  • Ongoing
  • 2023
  • 2019-2022

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Ipsos
abbvie
3M
Siemens Healthineers
Fresenius

Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X